Metabolic drugs in anti-ischemic therapy
Loading...
Date
Authors
Zakharenkova, A.
Візір, Марина Олександрівна
Vizir, Maryna
Визир, Марина Александровна
Journal Title
Journal ISSN
Volume Title
Publisher
Skleněný Můstek, Karlovy Vary, Czech Republic
Editor(s)
Abstract
The first drugs for anti-ischemic therapy were vitamins of group B, but their effectiveness was refuted in clinical trials. The next drug was trimetazidine, since it has a high cytoprotective effect. This drug is especially effective in patients with stable angina. But thiotriazoline is a new anti-ischemic drug that includes anti-ischemic, metabolic and antioxidant activity with minimal side effects. Summing up, given the good tolerability, efficacy and safety, thiotriazoline can be recommended as a remedy of metabolic therapy for the treatment of IHD in the elderly.
Description
Citation
Zakharenkova A. Metabolic drugs in anti-ischemic therapy / A. Zakharenkova // Science and Life : Proceedings of articles the international scientific conference, Skleněný Můstek, Karlovy Vary, Czech Republic, 16–17 November 2017. – Karlovy Vary, 2017. – P. 59–64.